An Adaptative Randomized Phase II Study on the Timing of FOLFOX for Patients With Operable Stage III Rectal Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Feb 2018
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 21 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 May 2018.
- 05 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017, as reported by ClinicalTrials.gov.